The FY2025 (Dec) proxy of GeneDx Holdings names 17 peer companies for pay. Among GeneDx Holdings and these peers, CEO pay was 3rd highest of 10 and total shareholder return was the highest of 10.
3rd highest of 10in GeneDx Holdings and its pay peers, FY2025 (Dec) by CEO pay:
$4.0M$15.0M
1st highest of 10in GeneDx Holdings and its pay peers, FY2025 (Dec) by total shareholder return:
$5$1,494
Pay peer group, FY2025 (Dec) proxy
| Natera | ||
| Twist Bioscience | ||
| Ultragenyx Pharmaceutical | ||
| Mirum Pharmaceuticals | ||
| Adaptive Biotechnologies | ||
| Veracyte | ||
| CareDx | ||
| 10x Genomics | ||
| Health Catalyst | ||
| Axogen | Not disclosed | Not disclosed |
| Castle Biosciences | Not disclosed | Not disclosed |
| Cerus | Not disclosed | Not disclosed |
| Fulgent Genetics | Not disclosed | Not disclosed |
| Myriad Genetics | Not disclosed | Not disclosed |
| Neogenomics | Not disclosed | Not disclosed |
| Pacific Biosciences of California | Not disclosed | Not disclosed |
| Standard BioTools | Not disclosed | Not disclosed |
17 companies
Changes by year
No proxy on file names a change to the peer group.
The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year. Each company counts TSR from its own start year, so two values compare only when the start years match.